BOULDER, Colo., Aug. 28, 2017 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will present at the 2017 Wells Fargo Healthcare Conference. The public is welcome to participate in the conference through a webcast on the Array BioPharma website. 



    Event:     Wells Fargo Healthcare Conference

    Presenter: Ron Squarer, Chief Executive Officer

    Date:      Wednesday, September 6, 2017

    Time:      9:05 a.m. Eastern Time

    Webcast:   https://cc.talkpoint.com/well001/090617a_as/?entity=65_KJWP5P3

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. Eight registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics).



    CONTACT:                                   Tricia Haugeto

                                               Array BioPharma Inc.

                                               303-386-1193

                                               thaugeto@arraybiopharma.com

View original content with multimedia:http://www.prnewswire.com/news-releases/array-biopharma-to-present-at-the-2017-wells-fargo-healthcare-conference-300507954.html

SOURCE Array BioPharma Inc.